SWHR Appoints Sarah Wells Kocsis New Vice President of Public Policy



WASHINGTON, DC (April 18, 2017) —The Society for Women’s Health Research (SWHR®) announced the hiring of Sarah Wells Kocsis, MBA, as its new Vice President of Public Policy. Kocsis will lead the organization’s national policy agenda, including shaping public discussion around issues impacting women’s health, and designing and implementing effective stakeholder engagement activities.

Kocsis brings more than 20 years of expertise in driving public policy solutions aimed at improving patient access to care. Most recently, Kocsis served as the Health Policy and Market Access Director at Hologic Inc., where she led and implemented policy, legislative, and reimbursement priorities for the company’s breast and skeletal health, and gynecologic surgery portfolio.

“I am thrilled that Sarah has joined our growing team,” said Amy M. Miller, PhD, president and CEO of SWHR. “She shares our values and focus on women’s health issues, and is uniquely qualified to serve in this important role with her outstanding legislative and regulatory experience in health policy.”

Previously, Kocsis worked at Amgen Inc., as the US Health Policy and Reimbursement Director, where she facilitated government interactions to secure and maintain appropriate Medicare and Medicaid coverage and reimbursement for Amgen products. Kocsis also established Boston Scientific’s first Washington, DC, government affairs office, where she managed the health program function and served as the primary interface with the Centers for Medicare and Medicaid Services, industry trade groups, and stakeholder coalitions.

“For over 27 years, SWHR has been the leading science-based advocate for advancing women’s health interests,” said Kocsis. “I am highly motivated to leverage this evidence-based platform to shape policy priorities on a number of critical and complex issues that impact the health and well-being of women.”

Kocsis received her Bachelor of Science degree in biology from Tulane University and earned an MBA from the University of Virginia Darden School of Business.

SWHR leads the way in advocating for greater funding for women’s health research and for the study of biological differences that affect disease; promotes the inclusion of women and minorities in medical research; pushes for the analysis of research data for sex and ethnic differences; and informs women, health care providers, and policymakers about contemporary women’s health issues.

###

About SWHR

The Society for Women’s Health Research (SWHR®) is a national non-profit based in Washington, DC. A thought-leader in promoting research on biological differences in disease, SWHR is dedicated to advancing women’s health through science, advocacy, and education. For more information, visit http://www.SWHR.org. Follow on Twitter at http://www.twitter.com/SWHR.

WASHINGTON, DC (April 18, 2017) —The Society for Women’s Health Research (SWHR®) announced the hiring of Sarah Wells Kocsis, MBA, as its new Vice President of Public Policy. Kocsis will lead the organization’s national policy agenda, including shaping public discussion around issues impacting women’s health, and designing and implementing effective stakeholder engagement activities.

Kocsis brings more than 20 years of expertise in driving public policy solutions aimed at improving patient access to care. Most recently, Kocsis served as the Health Policy and Market Access Director at Hologic Inc., where she led and implemented policy, legislative, and reimbursement priorities for the company’s breast and skeletal health, and gynecologic surgery portfolio.

“I am thrilled that Sarah has joined our growing team,” said Amy M. Miller, PhD, president and CEO of SWHR. “She shares our values and focus on women’s health issues, and is uniquely qualified to serve in this important role with her outstanding legislative and regulatory experience in health policy.”

Previously, Kocsis worked at Amgen Inc., as the US Health Policy and Reimbursement Director, where she facilitated government interactions to secure and maintain appropriate Medicare and Medicaid coverage and reimbursement for Amgen products. Kocsis also established Boston Scientific’s first Washington, DC, government affairs office, where she managed the health program function and served as the primary interface with the Centers for Medicare and Medicaid Services, industry trade groups, and stakeholder coalitions.

“For over 27 years, SWHR has been the leading science-based advocate for advancing women’s health interests,” said Kocsis. “I am highly motivated to leverage this evidence-based platform to shape policy priorities on a number of critical and complex issues that impact the health and well-being of women.”

Kocsis received her Bachelor of Science degree in biology from Tulane University and earned an MBA from the University of Virginia Darden School of Business.

SWHR leads the way in advocating for greater funding for women’s health research and for the study of biological differences that affect disease; promotes the inclusion of women and minorities in medical research; pushes for the analysis of research data for sex and ethnic differences; and informs women, health care providers, and policymakers about contemporary women’s health issues.

###

About SWHR

The Society for Women’s Health Research (SWHR®) is a national non-profit based in Washington, DC. A thought-leader in promoting research on biological differences in disease, SWHR is dedicated to advancing women’s health through science, advocacy, and education. For more information, visit http://www.SWHR.org. Follow on Twitter at http://www.twitter.com/SWHR.